×
For best experience we recommend to activate Javascript in your browser.
Angiopoietin 4 antibody (AA 272-489)
The Rabbit Polyclonal anti-Angiopoietin 4 antibody has been validated for WB, IHC, ICC and IP. It is suitable to detect Angiopoietin 4 in samples from Rat.
Quick Overview for Angiopoietin 4 antibody (AA 272-489) (ABIN7611173)
Target
See all Angiopoietin 4 (ANGPT4) Antibodies
Angiopoietin 4 (ANGPT4)
Reactivity
All reactivities for Angiopoietin 4 antibodies
Rat
Host
All hosts for Angiopoietin 4 antibodies
Rabbit
Clonality
All clonalities for Angiopoietin 4 antibodies
Polyclonal
Conjugate
All conjugates for Angiopoietin 4 antibodies
This Angiopoietin 4 antibody is un-conjugated
Application
All applications for Angiopoietin 4 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunoprecipitation (IP)
Product Details anti-Angiopoietin 4 Antibody
(hide)
Binding Specificity
All epitopes for Angiopoietin 4 antibodies
AA 272-489
Purpose
Angiopoietin 4 (ANGPT4) Polyclonal Antibody
Sequence
Arg272~Phe489
Characteristics
The Angiopoietin 4 (ANGPT4) Polyclonal Antibody (Species: Rat) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for Angiopoietin 4
(hide)
Target
Angiopoietin 4 (ANGPT4)
Alternative Name
ANGPT4
Gene ID
296269
UniProt
D3ZR43
Pathways
RTK Signaling
Recently viewed
(hide)
Chat with us , powered by LiveChat